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Abstract
Antimicrobial resistance (AMR) is a natural phenomenon in bacteria which 
becomes a threat for health-care settings around the world. A concerted global 
response is needed to tackle rising rates of antibiotic resistance, without it we risk 
returning to the pre antibiotic era. As bacteria evolve very fast according to the 
environment in which they inhabit via developing different defence mechanisms 
to combat with the noxious agents like different classes of antibiotics including 
carbapenems. This results into treatment failure and clinical complications. Global 
emergence of antibiotic resistance due to bacterial multidrug efflux pump systems 
are a major and common mechanism of intrinsic antimicrobial resistance employed 
by bacteria which are spreading rapidly due to over use or misuse of antimicrobial 
agents. This review mainly focusses on the transcriptional expression of efflux 
pump system AcrAB-TolC, local regulatory genes (AcrR and AcrS), mediating 
carbapenem resistance in clinical isolates of Escherichia coli under antibiotic stress, a 
genetic interplay study between intrinsic and acquired antibiotic resistance mecha-
nisms along with a brief summary on high risk factors and prevalence of urinary 
tract infections by multidrug resistant Uropathogenic Escherichia coli.
Keywords: Escherichia coli, carbapenem, AcrAB-TolC, blaNDM-1, uropathogenic 
Escherichia coli
1. Introduction
Distribution of multi-drug resistant bacteria is a chief public health issue. 
Mutations have been an important factor influencing the development of the 
multi-drug resistant phenotypes and elucidate how they acquire antibiotic resis-
tance [1, 2]. Several mutations are often required to acquire resistance towards a 
particular drug [3, 4]. However, a number of mechanisms evolved within bacteria 
helps them to survive against any noxious agents. Amongst the possible antibi-
otic resistance mechanisms, efflux pumps are membrane proteins which export 
noxious substances including antimicrobials out of the cell via over expressing 
the tripartite pump system resulting into antibiotic resistance [5]. Efflux pumps 
(like, AcrAB-TolC in Escherichia coli and MexAB-OprM in P. aerugiosa), are crucial 
for their survival and colonization/virulence, mainly during the development of 
infection when the pathogen is attacked by toxic substances or adhere with the host 
[6]. The AcrAB-TolC is constitutively expressed in Escherichia coli, and provides 
intrinsic resistance towards antimicrobials such as erythromycin and fusidic acid 
as well as dyes and detergents [7, 8]. In Klebsiella pneumonia, efflux pump medi-
ated tigecycline resistance was reported from China in which higher expression 
of efflux pump systems AcrAB-TolC and OqxAB was recorded and the expression 
of AcrB gene was found to be connected with ramA and marA expression [9]. For 
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decades, as a last resort carbapenems has been used quite effectively and the idea 
about this antibiotic was compromised due to the rise of carbapenem hydrolysing 
ß-Lactamase producers strain of Klebsiella pneumoniae [10]. Moreover, the situ-
ation is more convoluted in Indian subcontinent after appearance of New Delhi 
metallo-Beta lactamases in the present decade [11]. However, from India, in a study 
on P. aeruginosa isolates obtained from hospital revealed that MexAB-OprM efflux 
pump can considerably contribute to meropenem resistance in the absence of an 
acquired resistant mechanism [12]. According to a research done by Charleric B 
et al. 2003, clinical isolates of Enterobacter aerogenes exhibited resistance towards 
β-lactam and other group of antibiotics. Efflux pump associated resistance against 
quinolone, tetracycline and chloramphenicol along with over-expression of AcrA 
within these imipenem resistant strains have been observed earlier [13]. As per a 
study done by Chetri et al., 2019 a strong association between ertapenem resistance 
and AcrA over-expression was observed which has not been noticed earlier. Also, 
the over-expression of AcrB towards imipenem stress was noticed in this study is 
unique of its own [14]. AcrD, a transporter protein which belongs to RND super-
family of efflux pump was found to be associated with aminoglycosides resistance 
[15] did not show any role in carbapenem resistance in the above study [14]. Elkins 
and Nikaido in 2002, reported that for an efficient efflux of amphiphilic substrate, 
AcrD needs an association with AcrA in intact cells [16] and this association plays 
an important role in carbapenem non-susceptibility. Mutations in drug target genes 
are still presumed to be the crucial mechanism for drug resistance. To examine 
the basis of the increased expression of local regulators, AcrR and AcrS in AcrAB 
overexpressed isolates, mRNA sequencing of the regulatory regions was executed 
and was confirmed that the efflux pump mediated carbapenem resistance does not 
have any mutational event [16]. Dzwokai Ma and co-workers in 1996, reported that 
the transcriptional expression of AcrAB was increased under general stress condi-
tion and further, they investigated the role of the local repressor AcrR under general 
stress condition [16]. Remarkably, they found that under all these stress conditions, 
the transcription of AcrR was insistently increased and the level of increase was 
even higher than that observed for AcrA however, local repressor AcrR is associated 
as a repressor for AcrAB. In a study by Chetri and co-workers, the isolates with 
increased AcrAB expression under carbapenem stress showed much higher expres-
sion of AcrR which is surprising [14]. In agreement with the earlier study [14] it can 
be hypothesized that stress induced transcription of AcrAB is probably under the 
control of global transcriptional regulators.
New Delhi metallo beta-lactamase (NDM) is the predominant carbapenem 
resistance determinant in India which is harboured within members of enterobacte-
riaceae family and non-fermenters [17], and different variants have been reported 
from this country. Carbapenem resistance is a complex phenomenon which involves 
interplay between multiple acquired and intrinsic resistance mechanisms which 
includes loss or downregulation of porins, overexpression of different efflux 
pump systems and plasmid mediated acquirement of carbapenemase genes [18]. 
A previous study has noticed that efflux pump system plays an important role in 
carbapenem resistance compared to blaNDM-1 in Pseudomonas aeruginosa [18]. In 
another study, simultaneous expression of single component and multi component 
efflux pump was attempted in E. coli and Pseudomonas aeruginosa but it did not 
increase antibiotic resistance [19]. In similar work interplay between overexpression 
of AcrAB-TolC and mutation in gyrA and parC in quinolone resistance in E. coli 
was observed [20]. Also, a previous study has highlighted greater role of acrB in 
beta-lactam and quinolone resistance [21]. However, a study showed same pattern 
of transcriptional expression for both acrA and AcrB, which is probably due to 
the presence of both the genes in same transcript [22]. In a study done by Chetri 
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et al., 2019 showed that in an E. coli isolate over-expressing both AcrAB-TolC and 
blaNDM-1, showed higher level of mRNA for both the genes when compared with 
other groups (II, III and IV) [22] and was observed that even a smaller amount of 
imipenem and meropenem was able to trigger the expression of NDM although; 
the role of ertapenem in induction was still unclear. Unlike Pseudomonas aeruginosa, 
where expression of efflux pump system MexAB-OprM was significant than that of 
blaNDM-1 [18], a study found contrasting pattern in E. coli [14]. In Indian subcon-
tinent resistance against carbapenem is an evolving problem. However, acquirement 
of New Delhi metallo beta-lactamase is considered as the major reason for treat-
ment failure and along with that efflux pump mediated resistance too remains a 
matter of concern as together both the mechanisms pose a grander risk. Study done 
by Chetri et al., 2019 was able to highlight a higher mRNA transcript of both the 
resistance genes when coexist within an isolate [22] and require further investiga-
tion to identify the concentration of antibiotics, duration of exposure and other 
factors responsible induction of these intrinsic and acquired mechanisms that exert 
an isolate a multidrug resistant phenotype.
Further, the active participation of Escherichia coli in causing Urinary tract 
infections, which is mainly caused by Uropathogenic Escherichia coli (UPEC) are 
the common bacterial infections [23]. In females, the high risk of UTIs is due to the 
intrinsic virulence of E. coli for colonization in urinary tract such as its capabilities 
to adhere to the tract and its association with other microorganisms moving from 
the perineum regions to the warmth moist environment of the female genitalia 
contaminated with fecal microbes [24, 25]. The worldwide rise of multi-drug resis-
tant uropathogens, underscores the need for substitute non-antibiotic therapeutic 
and preventive approaches against Urinary tract infections.
However, a study done by Linsenmeyer et al. demonstrated a high level of 
indefinite empiric treatment for urinary tract infections caused by MDR gram-
negative bacteria and patients suffering from MDR UTI is treated with an inactive 
antimicrobial agent as their preliminary therapy [26]. As in the previous study, 
estimation of non-fluoroquinolone antibiotics demonstrated the enhancement in 
accuracy of empiric therapy, considered as key concepts for stewardship pro-
grams [26]. Though, based upon the severity of illness, other patient factors and 
favoured means of drug administration, the therapeutic options can be selected. 
However, the high usage of fluoroquinolone is disturbing with the emergence of 
high resistance rates [27–29].
Other than E. coli, Staphlylococcus aureus which is a common cause of infections 
in health-care facilities and also in the community are part of our skin flora. A new 
AMR indicator was introduced in 2019 in the SDG monitoring framework which 
observes the frequency of bloodstream infections caused by two particular drug 
resistant microbes: Escherichia coli resistant to third generation cephalosporins 
and methicillin-resistant Staphylococcus aureus (MRSA). Extensive resistance in 
extremely variable strains of N. gonorrhoeae has rapidly emerged and developed 
resistance towards macrolides, sulphonamides, fluoroquinolones, tetracyclines and 
early generation cephalosporins. The utilization of extended-spectrum cephalo-
sporin ceftriaxone in injectable form are the only available therapeutic option for 
gonorrhoea in most countries currently. The threat of carbapenem resistant entero-
bacteriaceae (CRE) is emmerging and numerous mechanisms are associated in their 
non-susceptibility against carbapenem. This situation complicates the therapeutic 
scenario in critical care conditions in hospital setting as carbapenem resistant 
pathogens are most commonly found to be multidrug resistant. The epidemiology 
and occurrence rate of CRE differs in different geographical regions [30].
Antimicrobial resistance is an intricate issue which requires a combined multi-
sectoral approach. One health approach brings together various divisions and 
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stakeholders involved in human, aquatic and terrestrial animals and plants health, 
feed and food production and the environment to interact and work together for 
designing and execution of programmes and research to accomplish improved 
public health outcomes. The research and development of novel antimicrobials, 
vaccines and rapid diagnostic tools especially for targeting dangerous gram-
negative bacteria like carbapenem resistant Enterobacteriaceae requires greater 
innovations and investments [30].
2. Conclusion
Multidrug efflux pumps are primeval elements encoded in the microorganism’s 
chromosomes which confer resistance to antibiotics at different levels: intrinsic 
resistance, acquired resistance, and transient induced phenotypic resistance. 
Additionally, multidrug efflux pumps exhibit various functions with relevance to 
bacterial adaptation to altered habitats. Some of these functions, like resistance to 
heavy metals, resemble antibiotic resistance, biocides, or solvents, as they are adap-
tive responses to diverse types of external injuries, whereas, others are associated 
to internal detoxification of intermediate toxic bacterial metabolites. AcrAB pump 
is an important antibiotic resistance determinant in bacterial pathogen, having a 
dynamic role in developing resistance towards carbapenem group of antibiotics 
and the role of regulatory genes in inducing the expression of these pumps high-
lights the fact that the regulators directly or indirectly involved in increasing the 
expression of efflux pump system leading towards the development of carbapenem 
resistant MDR Escherichia coli isolates in clinical settings.
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